BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for NLS Pharmaceutics AG (NLSP)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for NLS Pharmaceutics AG:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-12-16
4:45 pm
Purchase		 2022-12-06 13G NLS Pharmaceutics AG
NLSP		 BIOTECHNOLOGY VALUE FUND L P 171,479
19.990%		 171,479increase
(New Position)		 Filing